NIH Study Confirms Lutein-Zeaxanthin Formula Slows AMD Progression Better Than Beta-Carotene

For millions of older Americans, the slow erasure of central vision by macular degeneration has long been an irreversible sentence — treatable only in its pace, never its direction. Over a decade of rigorous federal research has now confirmed that a refined supplement formula, replacing a risky compound with two retinal antioxidants, not only slows the disease more effectively but does so without endangering the lives of those who smoke. It is a rare convergence in medicine: a safer path that is also the better one.